N C Karyotakis

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Correlation between In Vitro and In Vivo Activity of Antifungal Agents against Candida Species

E. Anaissie, N C Karyotakis, R. Hachem et al. · The Journal of Infectious Diseases · 1994 · 116 citations

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis

E. Anaissie, Ray Hachem, N C Karyotakis et al. · Antimicrobial Agents and Chemotherapy · 1994 · 64 citations · Full text

Murine Trichosporonosis, Medicinal Chemistry, Antifungal Agent +14

Comparison of the Efficacy of Polyenes and Triazoles against Hematogenous Candida krusei Infection in Neutropenic Mice

N C Karyotakis, E. Anaissie, Ray Hachem et al. · The Journal of Infectious Diseases · 1993 · 41 citations